BIOMAT Database Logo BIOMAT Database Logo

Hypercoagulability, hyperlipidemia, and serum antiproteases. 1985

P R Billings

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D001778 Blood Coagulation Disorders Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions. Coagulation Disorders, Blood,Disorders, Blood Coagulation,Blood Coagulation Disorder,Coagulation Disorder, Blood,Disorder, Blood Coagulation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000515 alpha 1-Antitrypsin Plasma glycoprotein member of the serpin superfamily which inhibits TRYPSIN; NEUTROPHIL ELASTASE; and other PROTEOLYTIC ENZYMES. Trypsin Inhibitor, alpha 1-Antitrypsin,alpha 1-Protease Inhibitor,alpha 1-Proteinase Inhibitor,A1PI,Prolastin,Serpin A1,Zemaira,alpha 1 Antiprotease,alpha 1-Antiproteinase,1-Antiproteinase, alpha,Antiprotease, alpha 1,Inhibitor, alpha 1-Protease,Inhibitor, alpha 1-Proteinase,Trypsin Inhibitor, alpha 1 Antitrypsin,alpha 1 Antiproteinase,alpha 1 Antitrypsin,alpha 1 Protease Inhibitor,alpha 1 Proteinase Inhibitor
D000990 Antithrombin III A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily. Heparin Cofactor I,Antithrombin III-Alpha,Atenativ,Heparin Co-Factor I,Kybernin,Serpin C1,Thrombate III,Antithrombin III Alpha,Antithrombin IIIAlpha,Cofactor I, Heparin,Heparin Co Factor I

Related Publications

P R Billings
Serum antiproteases and respiratory diseases of the horse.
January 1977, Folia veterinaria Latina,
P R Billings
Serum alarm antiproteases in systemic sclerosis patients.
September 2017, Human immunology,
P R Billings
Hyperlipidemia, hypercoagulability, and accelerated thrombosis: studies in congenitally hyperlipidemic rats and in rats and monkeys with induced hyperlipidemia.
February 1976, Blood,
P R Billings
Serum proteolytic activities and antiproteases in human colorectal carcinoma.
March 1998, Journal of physiology and biochemistry,
P R Billings
Hypercoagulability and reduced fibrinolysis in hyperlipidemia: relationship to the metabolic cardiovascular syndrome.
January 1992, Journal of cardiovascular pharmacology,
P R Billings
Hyperlipidemia and serum complement.
April 1998, Atherosclerosis,
P R Billings
Effect of smoking on peripheral blood leukocytes and serum antiproteases.
January 1985, European journal of respiratory diseases. Supplement,
P R Billings
Corneal ulceration and the serum antiproteases. I. Alpha 1-antitrypsin.
October 1973, Investigative ophthalmology,
P R Billings
Heparin resistance in relation to hyperlipidemia and hypercoagulability in atherosclerotic diabetics and non-diabetics.
January 1972, The Journal of the Egyptian Medical Association,
P R Billings
Proteases and antiproteases.
January 2001, Novartis Foundation symposium,
Copied contents to your clipboard!